Chlamydia screening drops after change in cervical cancer screening guideline

July 11, 2017, American Academy of Family Physicians

A 2012 cervical cancer screening guideline change is associated with reduced testing for cervical cancer and chlamydia and reduced identification of chlamydia cases in young women. Screening for chlamydia, the most commonly-diagnosed bacterial sexually transmitted infection worldwide, is often conducted with cervical cancer screening.

Using population-based physician billing claims data and data, researchers in Ontario, Canada assessed the population-level impacts of new screening guidelines recommending less frequent screening and older age of screening initiation.

They found that Pap testing declined in all age groups following the guideline release, with the greatest relative reductions observed for females aged 15 to 19 years. The guideline change was also followed by a decrease in testing in females aged 15 to 29 years. The largest reduction was observed in the 15 to 19-year age group (relative reduction of 26 percent), in whom cervical cancer screening is no longer recommended, suggesting that reduced chlamydia testing may have been an unintended consequence of the guideline change.

Reduced chlamydia testing coincided with a reduction in reported chlamydia incidence in females aged 15 to 19 years and 20 to 24 years (relative reductions of 17 percent and 14 percent, respectively). In contrast, there were small increases in in males aged 20 to 24 years and 25 to 29 years two years after the guideline change. Incidence rates were unchanged for males.

The authors call for separating screening recommendations for from recommendations for cervical cancer and highlight the need to promote chlamydia screening strategies for females that can be adopted into routine clinical care.

Explore further: Current performance measures for cervical cancer screening promote overscreening

More information: Annals of Family Medicine, www.annfammed.org/content/15/4/329

Related Stories

Current performance measures for cervical cancer screening promote overscreening

July 10, 2017
Following current performance measures that require adherence to strict time intervals for cervical cancer screening may promote overscreening. Changing cervical cancer screening performance measures to distinguish between ...

How have HPV vaccines affected cervical cancer screening?

June 7, 2017
A new review looks at cervical cancer screening in the era of HPV vaccination. The review notes that trials have demonstrated the efficacy and safety of vaccines against HPV infection, but the complete effect of HPV vaccination ...

Screening, HPV vaccine can prevent cervical cancer: FDA

February 8, 2017
(HealthDay)—Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says.

Chlamydia screening for pregnant young women prevents newborn complications, while saving health dollars

August 26, 2015
Chlamydia screening for all pregnant women aged between16 and 25 is cost-effective and can prevent harm to babies, a University of Melbourne study has found.

ACOG: New recommendations for cervical cancer screening

December 23, 2015
(HealthDay)—In a practice bulletin published in the January issue of Obstetrics & Gynecology, new recommendations are presented for cervical cancer screening and prevention.

New Pap smear schedule led to fewer chlamydia tests, new study suggests

July 20, 2015
It's a tale of two tests: one for early signs of cervical cancer, the other for a sexually transmitted disease. But a new study suggests that a change in the recommended schedule for one may have dramatically lowered the ...

Recommended for you

Anxious women may want to keep an eye on their bone health

May 18, 2018
(HealthDay)—As if older women didn't already worry enough about their bone health, new research suggests that anxiety may up their risk for fractures.

FDA approves first drug aimed at preventing migraines

May 18, 2018
(HealthDay)—The millions of Americans who suffer from migraine may have a new source of hope—the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday.

New strategy to cure chronic hepatitis B infection

May 18, 2018
Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption. ...

Resistance to antifungal drugs could lead to disease and global food shortages

May 17, 2018
Growing levels of resistance to antifungal treatments could lead to increased disease outbreaks and affect food security around the world.

Pig immunology comes of age: Killer T cell responses to influenza

May 17, 2018
Researchers from The Pirbright Institute, University of Bristol, Cardiff University and University of Oxford have generated tools that allow scientists to understand a vital area of the pig immune system which was previously ...

How intestinal worms hinder tuberculosis vaccination

May 17, 2018
New research in mice suggests that chronic infection with intestinal worms indirectly reduces the number of cells in lymph nodes near the skin, inhibiting the immune system's response to the Bacille Calmette-Guerin (BCG) ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.